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BACKGROUND: Sepsis in children is a significant cause of morbidity and mortality in the pediatric intensive care unit (PICU). Assessment of pediatric 
sepsis using serial Pediatric Logistic Organ Dysfunction 
(PELOD)-2 score can be used as a prognostic factor. The 
use of biomarkers of sepsis is also used for diagnosis and 
predicting outcomes. Many studies have suggested that 
C-reactive protein (CRP) and procalcitonin (PCT) can be 
used to predict mortality. 
METHODS: A  prospective  cohort  study  was  conducted to 
evaluate  CRP,  PCT,  PELOD-2 score  and  its combination 
as a predictive factor of mortality in sepsis. All patients 
admitted to PICU Haji Adam Malik General Hospital, 
Medan, from April to November 2019 with suspected 
sepsis were included in this study. Blood examination and 
PELOD-2 scores were examined in the first 24 hours.
RESULTS: A total of 79 children were included with a 
mortality rate 55.7%. The CRP, PCT, and PELOD-2 score 
were higher in nonsurvivor (2.8 (0.5-22.4) mg/dL; 9.36 
(0.13-79.8) ng/mL; 9 (3-21), respectively). In multivariate 
logistic regression analysis, neither CRP nor PCT values 
could be independent predictors of mortality. The PELOD-2 
score can be an independent predictor for mortality at 
a cut-off score of 7 (OR: 3.47 (95% CI: 1.68-7.19)). The 
combination of PELOD-2 and CRP scores as predictors of 
mortality showed lower values than PELOD-2 and PCT 
scores (0.80 vs. 0.95). The combination of all parameters 
only adds 1% of the predicted mortality value.
CONCLUSION: PELOD-2 score with PCT value are 
recommended to predict mortality children with sepsis.
KEYWORDS: sepsis, mortality, C-reactive protein, 
procalcitonin, PELOD-2 score
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Abstract
Introduction
Sepsis in children remains an important problem in 
morbidity and mortality worldwide. The mortality rate in 
the Pediatric Intensive Care Unit (PICU) in developing 
countries can reach to 50%.(1) According to the 2015 
Sepsis Prevalence Outcomes and Therapies (SPROUT), 
causes of infections come from the respiratory system by 
40%, while the occurrence of organ dysfunction occurs in 
67% of children with sepsis.(2) Previous study found that 
systemic inflammatory response syndrome (SIRS) occurred 
in 82% of PICU patients, of which 23% had sepsis, 4% 
severe sepsis, and 2% septic shock.(3) In the PICU of 
Cipto Mangunkusumo Central General Hospital, Jakarta, 
the percentage of sepsis presentations was 19.3% with a 
mortality rate of 10%.(4) A research at PICU of Haji Adam 
Malik General Hospital, Medan, showed the presentation of 
sepsis in boys was higher than girls with the most age was 
1-50 months (76.5%) and the mortality rate was 42%.(5)
 The new definition of sepsis was issued by The 
Society of Critical Care Medicine and The European 
Society of Intensive Care Medicine as life-threatening 
organ dysfunction.(6) Pathophysiological sepsis is a 
complex process between pathogens and the body's 
antibody system. In sepsis, there will be a dysregulation of 
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responses from cytokines. The anti-inflammatory response 
will cause immunosuppression which increases the 
patient, thus worsening the patient's condition. This causes 
mitochondrial dysfunction induced by cellular hypoxia. 
Cell and tissue damage will result in damage-associated 
molecular patterns (DAMPs), which will cause myocardial 
dysfunction, multiple organ failure (MOF), and death.(7) 
Organ dysfunction in sepsis can be assessed using pediatric 
logistic organ dysfunction (PELOD)-2 score.(8) 
 Currently, the use of biomarkers in sepsis is used to 
support rapid diagnosis and prediction of outcomes.(9) The 
widely used biomarker is C-reactive protein (CRP), which 
response to inflammation better than infection.(10) Sepsis 
begins with an inflammatory reaction due to infection 
that causes tissue damage. The stimulation of organisms 
to pathogen-associated molecular patterns (PAMPs) or 
DAMPs  will  cause  the  release  of  proinflammatory 
cytokines. This process stimulate hepatocyte cells to secrete 
CRP.(11) CRP can be used as a prediction of mortality in 
children with sepsis.
 Another biomarker used is procalcitonin (PCT). 
During inflammation, PCT is produced by two mechanisms, 
the direct pathway induced by lipopolysaccharides (LPS) or 
metabolic toxins from microbes, and the indirect pathways 
induced by inflammatory mediators such as interleukin 
(IL)-6, tumor necrosis factor (TNF)-α. In sepsis due to 
bacteria, PCT is also produced through alternative routes.
(12) Compared with CRP, PCT has a better diagnostic and 
prognostic value. PCT values increase as an inflammatory 
response caused by bacterial infection and several studies 
have suggested PCT as one of the promising markers in 
diagnosing sepsis and supporting antibiotic stewardship in 
systemic infections.(13) 
 Biomarkers in sepsis can be a supporting factor for 
diagnosis and therapeutic decision making. Early serum 
biomarkers can also be used to predict the prognosis in 
critically ill children.(10) Until now, there is no study 
before which compare the use of biomarkers such as CRP, 
PCT, PELOD-2 scores, or its combination in predicting the 
mortality of children with sepsis.
Methods
Study Design
This prospective cohort study was conducted in April to 
November 2019 in the PICU Haji Adam Malik General 
Hospital, Medan. Approval was taken from The Health 
Research Ethical Committee, Faculty of Medicine, 
Universitas Sumatera Utara/Haji Adam Malik General 
Hospital (No. 303/TGL/KEPK FK USU-RSUP HAM/ 
2019) and written consent was obtained from subject’s 
parents. Eighty-four subjects with sepsis were included 
for the study with inclusion criteria of age >28 days to <18 
years old, admitted to PICU. Pediatric surgical, trauma, or 
burn case was excluded. 
Method of Data Collection
The following data was collected for the eligible enrolled 
subjects: age, gender, primary organ involvement, and 
nutritional status. The PELOD-2 score was used to assess 
the severity of illness and organ dysfunction. This score 
illustrates multiple organ failure related to mortality, so 
that it can be used as a score to determine the possibility 
of subject mortality at PICU. This score consists of 5 organ 
systems that can show the presence of multiple organ 
dysfunction in sepsis. CRP and PCT were measured at 
admission, prior to antibiotic within 24 hours of admission 
in PICU. All subjects' outcome were followed up, either 
died or moved to the ward.
Statistical Analysis
Continuous variables were presented as medians (minimum-
maximum). Categorical variables were expressed as 
frequencies (%). Mann Whitney U test was used to assess 
the relationship between CRP, PCT, or PELOD-2 score 
with mortality. Multivariate logistic regression analysis 
was done to predict an outcome from a set of predictor 
variables in univariate analysis, with p<0.05 was considered 
statistically significant. The area under the receiver operator 
characteristic (ROC) was also used to assess the ability to 
predict the outcome. Statistical analysis was performed with 
SPSS version 22.0 program for Windows (IBM Corporation, 
New York, USA).
Results
Eighty-four subjects received therapy based on institutional 
protocol for sepsis. CRP or PCT examination was 
incomplete in 5 subjects, so only 79 subjects were included 
in the final analysis. There were 47 male (59.5%) and 32 
female (40.5%) subjects with mostly <1 year old (38%). 
The most indications treated at PICU were central nervous 
system disorders (30.4%) due to meningitis, respiratory 
system disorders (25.3%) due to bronchopneumonia, 
then shock (20.3%), with the length of stay was 1 to 34 
day. From this study, 44 subjects (55.7%) died. Children 
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Table 1. Basic characteristics of study participants at baseline.
with organ dysfunction  in sepsis were described with 
clinical, laboratory parameters, blood culture, and organ 
dysfunction assessed by PELOD-2 scores. The PELOD-2 
score in the lowest subjects was 2 and the highest was 21, 
with leukocytosis or leukopenia. The lowest CRP value 
in subjects  was  0.5  mg/dL  and  the  highest  reached 
22.4  mg/dL.  PCT  values  for  all  subjects  were  higher 
than normal values with the lowest value of 0.10 ng/mL to 
79.8 ng/mL. Bacterial growth was found in 51.9% blood, 
sputum, or urine culture. All characteristic data from the 
research sample can be seen in Table 1.
 In children with sepsis, CRP, PCT, and PELOD-2 
scores each had a significant association with mortality 
(p<0.001). As a marker of infection, CRP and PCT values 
in sepsis children were higher in those who died (2.8 (0.5-
22.4); 9.36 (0.13-79.8), respectively). The PELOD-2 score 
as an organ dysfunction score in pediatric sepsis also showed 
a higher score in nonsurvivor (9 (3-21)) than survivor (6 (2-
15)), p<0.05 (Table 2).
 In this study, initial CRP and PCT had optimal cut-
off points at 2.05 mg/dL and 5.4 ng/mL. In the univariate 
analysis, initial CRP values were higher in non-survival 
patients (OR: 1.79 (95% CI :1.15-2.78)) and same with initial 
PCT value (OR: 10.87 (95% CI: 3.67-32.17)). However, 
in multivariate regression analysis, neither CRP nor PCT 
values could be independent predictors of mortality. Only 
n = 79
<1 years old 30 (38)
1-<5 years old 13 (16.5)
5-<10 years old 10 (12.7)
10-<18 years old 26 (32.9)
Male 47 (59.5)
Female 32 (40.5)
12 (2.8-80)
96 (45-166)
Severe malnutrition 17 (21.5)
Mild-moderate malnutrition 17 (21.5)
Well-nourished 39 (49.4)
Overweight 6 (7.6)
Respiratory disorder 20 (25.3)
Cardiovascular disorder 4 (5.1)
Neurological disorder 24 (30.4)
Circulation disorder 16 (20.3)
Nephrology disorder 15 (19.0)
Survival 35 (44.3)
Death 44 (55.7)
14,900 (2,470-62,500)
1.9 (0.7-39)
2.1 (0.5-22.4)
6.1 (0.10-79.8)
8 (2-21)
Positive 41 (51.9)
Negative 38 (48.1)
PELOD-2 score, median (min-max)
Culture result, n (%)
ICU indication, n (%)
Outcome, n (%)
Leucocyte count (/µL), median (min-max)
Blood lactate (U/L), median (min-max)
CRP (mg/dL), median (min-max)
PCT (ng/mL), median (min-max)
Indicator
Age, n (%)
Gender, n (%)
Body weight (kg), median (min-max)
Body height (cm), median (min-max)
Nutritional status, n (%)
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Table 2. Association CRP, PCT, and PELOD-2 score with mortality. 
Discussion
Sepsis still become the cause of death in children in the 
last two decades, especially in developing countries. Study 
in China obtained a mortality rate of 34.6% in sepsis and 
severe sepsis of children, two-thirds of deaths occurred 
within 72 hours of treatment.(14) Another study in Columbia 
described there were 50% of pediatric patients treated in 
PICU with shock sepsis and 40% experienced multiple 
organ dysfunction syndrome, with a mortality rate of 34%.
(15) A large-scale study in 2015 found that the mortality 
Non-survivor Survivor
CRP (mg/dL) 2.8 (0.5-22.4) 1.2 (0.5 – 5.3) <0.001
PCT (ng/mL) 9.36 (0.13-79.8) 1.57 (0.10 – 25.0) <0.001
PELOD-2 score 9 (3-21) 6 (2-15) <0.001
Parameter p -value*
Median (min-max)
*Analyzed with Mann-Whitney test.
Univariate Multivariate
CRP (mg/dL) 1.79 (1.15-2.78)
PCT (ng/mL) 10.87 (3.67-32.17)
PELOD-2 score 3.47 (1.68-7.19) 8.39 (1.22-57.88) <0.05
OR (95% CI)
p -value**Parameter
**Analyzed with logistic regression analysis. OR: odds ratio; CI: confidence interval.
Table 3. Univariate and multivariate analysis for CRP, PCT, PELOD-2 score as predictive 
factor of mortality in sepsis.
the PELOD-2 score could be an independent predictor for 
mortality at a cut-off point of 7 with an OR of 3.47 (95% CI: 
1.68-7.19) (Table 3).
 The PELOD-2 scores gave a moderate strength area 
under the receiver operating characteristic (ROC) curve 
(AUC) values as predictors of mortality (AUC: 0.75). The 
addition of biomarkers increases the predictor value where 
the PELOD-2 score and CRP were lower than assessing 
the PELOD-2 score and PCT (AUC: 0.80 vs. 0.95). All 
assessments  of  PELOD-2  score,  CRP  and  PCT  only  add 
1% compared to the PELOD-2 score and PCT, so adding 
CRP  did  not  give  a  significant  value.  In  this  study, 
PELOD-2 scores combination with PCT were recommended 
for predicting mortality in children with sepsis (Table 4, 
Figure 1).   
rate due to sepsis in children worldwide was 25%.(2) In 
this study, the mortality rate was 55.7%, where the most 
indication of PICU was central nervous system disorders.
 In the pediatric population, PELOD-2 scores are used 
to assess organ dysfunction. The PELOD-2 scores serials are 
related to prognostic of death.(16) In this study, PELOD-2 
scores in patients with sepsis at PICU were higher in non-
survivor than survivor patients (9 (3-21)) vs. 6 (2-15), 
respectively). Multivariate analysis of this study showed 
the PELOD-2 score could be an independent predictor for 
mortality in children with sepsis with cut-off point score 
7. However, the AUC did not show strong strength value 
(AUC: 0.75), so that it was better combined with biomarker 
examination.
 The use of biomarkers in pediatric sepsis can indicate 
the severity of sepsis. In addition, biomarkers are used to 
assess prognosis, guidelines for administering antibiotic 
therapy, evaluation of therapeutic response, or prediction 
of complications and organ dysfunction in sepsis.(17) 
Biomarker examinations for infections such as CRP and 
PCT are often performed before starting antibiotic treatment. 
This study compared PELOD-2 scores and its combination 
with CRP, PCT, or both in predicting mortality.
 CRP is an inflammatory cytokine. Existing studies 
assess CRP as a marker of diagnosis infection and prognosis 
in sepsis. Other study in critically ill adults showed serial 
CRP could be a good predictor of prognosis compared to 
other biomarkers. It was also used to assess therapeutic 
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Parameter AUC p -value**
PELOD-2 score 0.75 (0.64-0.86) <0.001
PELOD-2 score and CRP 0.80 (0.70 – 0.90) <0.001
PELOD 2 score and PCT 0.95 (0.90 – 1.0) <0.001
PELOD 2 score and CRP and PCT 0.96 (0.93-1.0) <0.001
Table 4. AUC predictor mortality in children with sepsis.
**Analyzed with logistic regression analysis. AUC: area under the ROC curve.
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Figure 1. ROC curve of CRP, PCT, and 
PELOD-2 score as a predictor of mortality in 
children with sepsis.
response.(18) In this study, there was a relationship between 
CRP values and mortality, where CRP was higher in 
nonsurvivor compared to survivor patients (2.8 (0.5-22.4) 
vs. 1.2 (0.5-5.3), p<0.001). However, CRP alone could 
not be an independent predictor of mortality in this study. 
Similar to another study of 172 children, a cut-off 7.1 mg/dL 
CRP was associated with organ dysfunction and mortality in 
hospitalized children. A combination with ferritin increased 
the predicted mortality value by more than 20% compared 
to CRP assessment alone. Increased CRP value alone (not 
above the cut-off point) was not related to mortality in 
the study.(19) In accordance with the results of the CRP 
examination in this study, the cut-off point of 1.2 mg/dL was 
lower compared to the results from previous studies.
 PCT is not released into circulation under normal 
circumstances. Several studies had assessed PCT as a 
diagnostic and predictive factor for outcomes in sepsis 
patients. PCT has a higher prognostic value for bacterial 
infection and mortality more than other markers of SIRS 
such as temperature, tachycardia, tachypnea, and elevated 
leukocytes.(20) Research on 175 children with sepsis shock 
showed the initial PCT value was higher in children with 
multiple organ failure and mortality.(21) A study in children 
with sepsis at PICU showed high PCT values in non-survivor. 
The results of the ROC curve and the AUC value showed a 
result of 0.83 (95% CI 0.77-0.88) with a cut-off of 47 ng/
mL.(22) Similar to this study, the median PCT was high in 
patients who were died compared to living (9.36 (0.13-79.8) 
vs. 1.57 (0.10-25), p<0.001). However, like CRP, the initial 
PCT value was not significant as an independent predictor 
in multivariate analysis. In children, there is no single 
biomarker that is claimed to be a good predictor of outcome. 
Complex interactions between immune responses and gene 
variations cause wide differences in examination results, 
so a combination of assessment variables is recommended.
(23,24) Multicenter studies in sepsis patients in Korea also 
showed that CRP and PCT values respectively could not be 
independent predictors in multivariate logistic regression 
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tests for mortality.(25) A prospective cohort study in India 
showed no significant association between CRP and PCT 
with mortality (p=0.839, p=0.346, sequential).(9)
 In this study, the PELOD score -2 could be an 
independent predictor of mortality. The addition of PCT 
would increase the predictor strength to AUC 0.95. While 
the addition of CRP to PELOD-2  increased the predictor 
of mortality to AUC 0.80. Multivariate analysis of all 
parameters did not significantly increase the strength of the 
AUC compared to the assessment of the PELOD-2 score 
combination with PCT. The PELOD-2 scores combination 
with PCT were recommended to be a predictor of mortality 
in children with sepsis. 
 There are some limitations in this study. First, the 
subjects were only children treated in PICU with sepsis, 
no control subjects were included in this study. Second, 
this study only analyzed initial biomarkers and PELOD-2 
scores, with no serial evaluation. This is a single center 
study so the cut-off values and recommendations obtained 
cannot be generalized. 
Conclusion
Assessment of pediatric sepsis with PELOD-2 scores can 
be an independent prognostic factor with a cut-off point of 7 
at the study center. The PELOD-2 score combined with the 
value of PCT was recommended to be a predictive factor of 
mortality. Further large scale multicenter research studies 
are needed to assess CRP, PCT, and PELOD-2 scores for 
early prognostication in children with sepsis.
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